Date: 21 March 2018
Time: 2.00 PM – 4.00 PM (GMT)
Spaces are limited. Register today to avoid missing out!
The technical call will aim to cover aspects such as:
- Analytical Method Validation (intro/background)
- Screening of method validation parameters (ICH Q2(R1) from a regulator’s eye, with focus on chromatography
- Method Validation Requirements – Clinical Study vs Marketing Authorisation
- Lifecycle management of Method Validation considering recently published draft ICH Q12 Guidance
- Evolving global regulatory landscape and regulatory issues encountered for analytical method validation
Please register your interest by 09 March if you would like to join the webinar and participate in the above discussion.
Please provide feedback on the above areas with relevant questions and experiences that you are willing to share during this interactive webinar to sarah.fitzgerald@pfizer.com by 13 March 2018.
To book: This webinar is now full, please email membership@topra.org to join the waiting list.